Bal Pharma Limited — Others, 25-03-2025: Trading Window

Bal Pharma has announced a board meeting to declare the audited financial results for the quarter and financial year ended 31 March 2025. Consequently, the trading window for its securities will be closed for designated persons and their immediate relatives from 1 April 2025 until 48 hours after the results are announced. This closure aligns with the company's internal code of conduct and aims to prevent insider trading.

The closure of the trading window may lead to cautious trading activity among investors as they await financial performance insights. Depending on the results, this could either bolster investor confidence or highlight potential concerns impacting share performance moving forward.